Cargando…
COVID-19 vaccines for patients with haematological conditions
Autores principales: | Sun, Clare, Pleyer, Christopher, Wiestner, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012057/ https://www.ncbi.nlm.nih.gov/pubmed/33811822 http://dx.doi.org/10.1016/S2352-3026(21)00073-9 |
Ejemplares similares
-
The antibody response of haematological malignancies to COVID-19 infection and vaccination
por: Seebacher, Nicole A.
Publicado: (2022) -
Humoral and Cellular Immunogenicity of COVID-19 Vaccinations in Patients with CLL
por: Sun, Clare, et al.
Publicado: (2021) -
Booster and Btki Interruption Improve Response to Sars-Cov-2 Vaccine in Patients with CLL
por: Bryer, Emily, et al.
Publicado: (2022) -
COVID-19 and haematological malignancy: navigating a narrow strait
por: Rubinstein, Samuel M, et al.
Publicado: (2020) -
CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL
por: Bryer, Emily, et al.
Publicado: (2022)